Global Propranolol Market 2023-2030

    In Stock

    Coming Soon




    The pharmaceutical propranolol, also marketed under the name Inderal, is a member of the beta-blocker group of medications.


    It is mostly used to treat cardiac rhythm problems, excessive blood pressure, and other cardiovascular diseases like angina and heart failure. It functions by preventing the heart and blood arteries from being affected by the hormone adrenaline, which can lower blood pressure and lessen the strain on the heart.


    Propranolol has been used off-label to treat anxiety, stage fright, migraines, and tremors in addition to its cardiovascular applications. Some forms of glaucoma may also be treated with it.


    Like other medicines, propranolol may have unwanted effects, some of which include low blood pressure, depression, sexual dysfunction, lethargy, dizziness, and low blood pressure.


    It should be taken with caution in patients with asthma or other respiratory disorders since it may also hide the signs of low blood sugar in diabetics. 




    infographic: Propranolol Market, Propranolol Market Size, Propranolol Market Trends, Propranolol Market Forecast, Propranolol Market Risks, Propranolol Market Report, Propranolol Market Share


    Global Propranolol market accounted for $XX Billion in 2022 and is anticipated to reach $XX Billion by 2030, registering a CAGR of XX% from 2023 to 2030.



    Propranolol has recently gained interest for its ability to treat children’s PTSD symptoms. Randomized clinical trials are necessary, nonetheless, to verify its efficacy.


    Additionally, as they may reduce the longevity of patients with cirrhosis, nonselective beta-blockers like propranolol should be stopped or avoided in patients with intractable ascites.


    Although propranolol is typically well taken, it can have unwanted effects like vivid or strange nightmares, angina flare-ups, and in rare cases, heart attacks. Elderly individuals could be more vulnerable to these consequences.



    Inflammation is one of the many abnormalities that COVID-19 patients experience because the SARS-CoV-2 virus compromises the immune system. Beta-blockers may assist to lessen this inflammation and restore the immune system’s balance.


    A common beta-blocker called metoprolol may be helpful in treating COVID-induced ARDS, according to a study that was published in the Journal of the American College of Cardiology.


    COVID-19 patients with ARDS were randomised to receive metoprolol medication or to be in a control group that got no further care.The findings imply that metoprolol may be a straightforward and affordable treatment for ARDS in COVID patients.





    1. How many Propranolol are manufactured per annum globally? Who are the sub-component suppliers in different regions?
    2. Cost breakup of a Global Propranolol and key vendor selection criteria
    3. Where is Propanolol manufactured? What is the average margin per unit?
    4. Market share of Global Propranolol market manufacturers and their upcoming products
    5. Cost advantage for OEMs who manufacture Global Propranolol in-house
    6. key predictions for next 5 years in Global Propranolol market
    7. Average B-2-B Propranolol market price in all segments
    8. Latest trends in Propranolol market, by every market segment
    9. The market size (both volume and value) of the Propanolol market in 2023-2030 and every year in between?
    10. Production breakup of Propranolol market, by suppliers and their OEM relationship


    Sl no Topic
    1 Market Segmentation
    2 Scope of the report
    3 Abbreviations
    4 Research Methodology
    5 Executive Summary
    6 Introduction
    7 Insights from Industry stakeholders
    8 Cost breakdown of Product by sub-components and average profit margin
    9 Disruptive innovation in the Industry
    10 Technology trends in the Industry
    11 Consumer trends in the industry
    12 Recent Production Milestones
    13 Component Manufacturing in US, EU and China
    14 COVID-19 impact on overall market
    15 COVID-19 impact on Production of components
    16 COVID-19 impact on Point of sale
    17 Market Segmentation, Dynamics and Forecast by Geography, 2023-2030
    18 Market Segmentation, Dynamics and Forecast by Product Type, 2023-2030
    19 Market Segmentation, Dynamics and Forecast by Application, 2023-2030
    20 Market Segmentation, Dynamics and Forecast by End use, 2023-2030
    21 Product installation rate by OEM, 2023
    22 Incline/Decline in Average B-2-B selling price in past 5 years
    23 Competition from substitute products
    24 Gross margin and average profitability of suppliers
    25 New product development in past 12 months
    26 M&A in past 12 months
    27 Growth strategy of leading players
    28 Market share of vendors, 2023
    29 Company Profiles
    30 Unmet needs and opportunity for new suppliers
    31 Conclusion
    32 Appendix
      Your Cart
      Your cart is emptyReturn to Shop